Solid Biosciences Inc. (SLDB) DCF Valuation

Solid Biosciences Inc. (SLDB) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Solid Biosciences Inc. (SLDB) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the Solid Biosciences Inc. (SLDB) DCF Calculator! Explore genuine Solid Biosciences financials, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of Solid Biosciences Inc. (SLDB).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 13.6 8.1 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 -40.57 -100 -35.14 -35.14 -35.14 -35.14 -35.14
EBITDA -116.5 -84.4 -69.3 -96.9 -93.4 .0 .0 .0 .0 .0
EBITDA, % 100 100 -508.74 -1196.76 100 20 20 20 20 20
Depreciation 2.8 3.9 3.0 2.4 2.6 .0 .0 .0 .0 .0
Depreciation, % 100 100 21.76 29.75 100 70.3 70.3 70.3 70.3 70.3
EBIT -119.3 -88.3 -72.3 -99.3 -96.0 .0 .0 .0 .0 .0
EBIT, % 100 100 -530.5 -1226.51 100 20 20 20 20 20
Total Cash 83.5 154.7 207.8 213.7 123.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .1 .0 .0
Account Receivables, % 100 100 0.80764 0 100
Inventories .0 .0 6.0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 44.16 0 100 68.83 68.83 68.83 68.83 68.83
Accounts Payable 7.1 3.3 4.5 3.2 2.0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 32.77 40 100 74.55 74.55 74.55 74.55 74.55
Capital Expenditure -4.4 -.9 -1.3 -3.0 -1.5 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 -9.41 -37.25 100 -9.33 -9.33 -9.33 -9.33 -9.33
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -117.7 -90.1 -72.2 -75.6 -96.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -112.1 -90.9 -75.4 -71.3 -96.2 -2.0 .0 .0 .0 .0
WACC, % 11.37 11.39 11.39 11.14 11.39 11.34 11.34 11.34 11.34 11.34
PV UFCF
SUM PV UFCF -1.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -48
Equity Value 46
Diluted Shares Outstanding, MM 20
Equity Value Per Share 2.31

What You Will Get

  • Comprehensive SLDB Financial Data: Pre-loaded with Solid Biosciences' historical and projected figures for detailed analysis.
  • Customizable Template: Easily adjust key metrics such as revenue growth, WACC, and EBITDA %.
  • Instant Calculations: Watch Solid Biosciences' intrinsic value refresh immediately based on your adjustments.
  • Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
  • Intuitive Design: Clear layout and straightforward instructions suitable for users of all skill levels.

Key Features

  • Comprehensive DCF Calculator: Offers in-depth unlevered and levered DCF valuation models tailored for Solid Biosciences Inc. (SLDB).
  • WACC Calculator: Features a ready-to-use Weighted Average Cost of Capital sheet with adjustable parameters.
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit your analysis.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Solid Biosciences Inc. (SLDB).
  • Interactive Dashboard and Charts: Visual representations provide a summary of essential valuation metrics for straightforward analysis.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Solid Biosciences Inc.'s (SLDB) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth projections, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation results.
  • 5. Present with Assurance: Share professional valuation insights to enhance your decision-making process.

Why Choose This Calculator for Solid Biosciences Inc. (SLDB)?

  • Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for biotech companies.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios for SLDB.
  • Detailed Insights: Automatically computes Solid Biosciences’ intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and biotech consultants focused on SLDB.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Solid Biosciences Inc. (SLDB) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Solid Biosciences Inc. (SLDB).
  • Consultants: Deliver professional valuation insights on Solid Biosciences Inc. (SLDB) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Solid Biosciences Inc. (SLDB) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Solid Biosciences Inc. (SLDB).

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Solid Biosciences Inc. (SLDB).
  • Real-World Data: Solid Biosciences' historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to simulate various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for decision-making.

Es wurden keine passenden Produkte gefunden.